01 1Aurisco Pharmaceutical
01 1BRIVARACETAM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-19
Pay. Date : 2020-01-21
DMF Number : 34511
Submission : 2020-01-22
Status : Active
Type : II
20
Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is BRIVARACETAM, with a corresponding US DMF Number 34511.
Remarkably, this DMF maintains an Active status since its submission on January 22, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 19, 2020, and payment made on January 21, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
